← Open Payments lookup

REBECCA ROCHFORD BUCKLEY: Open Payments

NPI 1306613906 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,697 in 165 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $2,638 · 2025 $3,697

Food & beverage: $3,693Education: $4
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.19$506
Axsome Therapeutics, Inc.8$352
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$335
ABBVIE INC.14$293
Teva Pharmaceuticals USA, Inc.21$262
Vanda Pharmaceuticals Inc.9$258
Alkermes, Inc.13$255
Otsuka America Pharmaceutical, Inc.11$255
Bausch Health US, LLC10$225
Takeda Pharmaceuticals U.S.A., Inc.8$198

Products named: INGREZZA, Auvelity, CAPLYTA, REXULTI, VRAYLAR, HETLIOZ, ARISTADA, APLENZIN.

Industry payments across FL — which companies pay providers there.